Stocks and Investing Stocks and Investing
Tue, October 5, 2021
Mon, October 4, 2021

Joshua Jennings Maintained (ABT) at Buy and Held Target at $140 on, Oct 4th, 2021


Published on 2024-10-27 18:03:30 - WOPRAI, Joshua Jennings
  Print publication without navigation


Joshua Jennings of TD Cowen, Maintained "Abbott Laboratories" (ABT) at Buy and Held Target at $140 on, Oct 4th, 2021.

Joshua has made no other calls on ABT in the last 4 months.



There are 10 other peers that have a rating on ABT. Out of the 10 peers that are also analyzing ABT, 1 agrees with Joshua's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Danielle Antalffy of "SVB Leerink" Maintained at Hold with Increased Target to $128 on, Tuesday, July 20th, 2021


These are the ratings of the 9 analyists that currently disagree with Joshua


  • Joanna Wiensch of "Citigroup" Maintained at Strong Buy with Increased Target to $140 on, Friday, October 1st, 2021
  • Bob Hopkins of "B of A Securities" Maintained at Strong Buy and Held Target at $133 on, Tuesday, August 31st, 2021
  • Marie Thibault of "BTIG" Maintained at Strong Buy with Increased Target to $136 on, Tuesday, August 31st, 2021
  • Larry Biegelsen of "Wells Fargo" Maintained at Buy and Held Target at $135 on, Tuesday, August 3rd, 2021
  • Raj Denhoy of "Jefferies" Maintained at Strong Buy with Increased Target to $130 on, Sunday, August 1st, 2021
  • Matt Miksic of "Credit Suisse" Maintained at Buy with Increased Target to $130 on, Friday, July 23rd, 2021
  • Cecilia Furlong of "Morgan Stanley" Maintained at Buy with Increased Target to $136 on, Friday, July 23rd, 2021
  • Jayson Bedford of "Raymond James" Maintained at Buy with Increased Target to $128 on, Friday, July 23rd, 2021
  • Rick Wise of "Stifel" Maintained at Strong Buy with Increased Target to $130 on, Thursday, July 22nd, 2021
Contributing Sources